Spatial transcriptomics is revolutionizing clinical and biomedical research by providing spatially resolved insights into tissue architecture, cellular topology, and morphological organization. This innovative technology enables the simultaneous profiling of gene expression and spatial location within tissues, uncovering multifaceted cellular interactions. In cancer, spatial transcriptomics guides the development of immunotherapy and targeted therapy by identifying spatially distinct expression patterns associated with tumor heterogeneity. This nuanced approach enhances precision medicine strategies by enabling tailored interventions that are informed by the complex spatial architecture and the entangled transcriptomic landscape of individual tissues. As a powerful tool in biomedical research, spatial transcriptomics—named Method of the Year 2020 by Nature Methods—is transforming our ability to resolve complex cellular interactions and close-range dynamics within their native spatial context, driving more effective and personalized therapeutic interventions.